1,2-Benzodiazepine

Generic Name: 1,2-Benzodiazepine

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₉H_₈N_₂

CAS Number: 264-60-8

Unique Ingredient Identifier: M0Q7802G2B

Background: Benzodiazepine is under investigation for the prevention of Delirium and C.Surgical Procedure; Cardiac. Benzodiazepine has been investigated for the treatment of Obesity, Sleep Apnea, Obstructive, and Disorders of Gallbladder, Biliary Tract and Pancrease.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Maternal and Neonatal Outcomes Following Exposure to Benzodiazepines During Pregnancy

Completed

Conditions: Pregnancy Related
Benzodiazepines Causing Adverse Effects in Therapeutic Use
Congenital Anomaly

Interventions: Drug: Benzodiazepine

First Posted Date: 2021-04-23

Last Posted Date: 2022-03-07

Lead Sponsor: Sungkyunkwan University

Target Recruit Count: 3094227

Registration Number: NCT04856436

Locations: 🇰🇷
Sungkyunkwan University, Suwon, Gyeonggi-do, Korea, Republic of

Benzodiazepines in Opiate Replacement Therapy

Completed

Conditions: Substance-Related Disorders

Interventions: Drug: Benzodiazepine

First Posted Date: 2020-11-10

Last Posted Date: 2023-03-09

Lead Sponsor: University of Stirling

Target Recruit Count: 46899

Registration Number: NCT04622995

Locations: 🇬🇧
NHS Scotland, Edinburgh, Scotland, United Kingdom

Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia

Completed

Conditions: Schizophrenia
Schizoaffective Disorder

Interventions: Drug: Mood stabilizer
Drug: Antipsychotic
Drug: Antidepressant
Drug: Benzodiazepine

First Posted Date: 2016-05-18

Last Posted Date: 2024-05-01

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 81921

Registration Number: NCT02775864

Decreasing the Incidence of Delirium After Cardiac Surgery

Phase 4

Withdrawn

Conditions: C.Surgical Procedure; Cardiac
Delirium

Interventions: Drug: Benzodiazepine
Drug: Propofol
Drug: Fentanyl

First Posted Date: 2014-04-22

Last Posted Date: 2018-06-12

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT02119806

Locations: 🇺🇸
Ronald Reagan UCLA Medical Center, Department of Anesthesiology, Los Angeles, California, United States

IMPACT: A Study to Explore the Efficacy and Safety of Paliperidone ER in Patients With Acute Agitation

Phase 4

Completed

Conditions: Psychomotor Agitation
Acute Disease

Interventions: Drug: Paliperidone ER
Drug: Benzodiazepine

First Posted Date: 2010-01-15

Last Posted Date: 2016-02-09

Lead Sponsor: Janssen Cilag N.V./S.A.

Target Recruit Count: 56

Registration Number: NCT01050478

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy